LGR5 and cancer: Expression levels of cancer stem cell (CSC) marker genes Lgr5, Smoc2, Axin2, Rnf43, and CD44 were markedly reduced in Prrc2a‐deficient tumors induced by AOM‐DSS treatment (Figure 2A,B).